Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Ultrasound Patch Accelerates Venous Wound Healing

By HospiMedica International staff writers
Posted on 14 Aug 2013
An innovative prototype low frequency ultrasound (US) patch delivers energy directly to a venous ulcer wound, promoting healing.

Developed by researchers at Drexel University (Philadelphia, PA, USA), the new technique for treating chronic venous stasis ulcers uses a novel ultrasound applicator that can be worn like a band-aid, which delivers low-frequency (in the 20–100 kHz range), low-intensity, US energy directly to the wounds. More...
In order to determine the optimal US frequency as well as treatment duration, the researchers treated five patients with either 15 minutes of 20 kHz US, 45 minutes of 20 kHz US, 15 minutes of 100 kHz US, or 15 minutes of a sham (placebo) US.

The researchers found that the group receiving 15 minutes of 20 kHz US showed the greatest improvement, with all five patients experiencing complete healing by the fourth treatment. The clinical findings were corroborated by an in vitro study in which mouse fibroblasts experienced on average a 32% increase in cell metabolism and a 40% increase in cell proliferation compared with control cells 24 hours after receiving 20 kHz ultrasound for 15 minutes.

The battery-powered patch incorporates a transducer that produces medically relevant energy levels using minimum voltage and weighs just 100 grams, connected to two lithium ion batteries, which are fully rechargeable. The design gives patients the option of using the transducer in a home environment, while still wearing compression socks. It also prevents the need for a doctor’s visit, which can be a difficult task for patients with chronic wounds. The study describing the new US patch was published in the August 2013 issue of the Journal of the Acoustical Society of America.

“There have been studies on the therapeutic benefits of ultrasound for wound healing, but most of the previous research was performed at much higher frequencies, around 1–3 megahertz,” said lead author professor of biomedical engineering Peter Lewin, PhD. “We had an idea that if we went down to the range of 20 to 100 kilohertz, which is at least an order of magnitude lower, we might see more profound changes; that’s exactly what happened.”

The researchers anticipate that patients with other types of chronic wounds such as diabetic or pressure ulcers may also benefit from therapeutic US. As a result, they have developed and are currently testing a diagnostic monitoring component that uses near infrared spectroscopy (NIRS) to noninvasively assess changes in the wound bed, which could reveal whether a treatment is working in its earliest stages, when healing is difficult to detect with the naked eye.

Related Links:

Drexel University



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
X-Ray Meter
Cobia SENSE
Infant Resuscitator
Easypuff
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.